You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3626 to 3650 of about 5880
Next 25
04/20/2008
Outpatient brain tumor surgery: innovation in surgical neurooncology.
Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme.
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors
Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults
Unique vaccine helps man with cancer (GBM)
04/17/2008
Patient Trial For Virus That Attacks Brain Cancer Cells
Heroes Of Hope Silent Auction Takes Place April 26 (Virginia)
TransMolecular Unveils First Data on TM601 Anti-Angiogenic Mechanism-of-Action at AACR Annual Meeting -Data also reveal peptide’s synergistic interactions with anti-VEGF therapeutics-
Drugs in the pipeline: new therapies that could change treatment strategies
04/16/2008
Updated Survivor Story - 14 years GBM survivor Peter!
04/14/2008
NOVOCURE PRESENTS RESULTS FROM BREAST CANCER PILOT STUDY (Mentions GBM also)
04/06/2008
Time course of imaging changes of GBM during extended bevacizumab treatment.
A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients.
04/01/2008
Golf Tournament for brain tumor research - June 23, 2008 - Sacramento, CA
Veterinary college researcher studying brain tumors in people and animals
03/31/2008
FREE CAREGIVER TRAINING DAY - Rochester, NY
03/30/2008
Phase II Pilot Study of Bevacizumab in Combination With Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability.
Added survivor story: Rose
Prenatal ultrasound and the risk of childhood brain tumour and its subtypes.
IBTA Newsletter
OncoMethylome Sciences Grants Commercial License To LabCorp For MGMT Methylation Testing
Reduced Glioma Growth Following Dexamethasone or Anti-Angiopoietin 2 Treatment.
Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.
Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma.
Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: Phase 1 trial in adults with malignant glioma.